Datopotamab Deruxtecan, Datroway, TROP-2 inhibitor Secondary Keywords: Breast cancer, antibody-drug conjugate

Breast cancer remains one of the most prevalent and challenging cancers worldwide, with over 300,000 new cases diagnosed annually in the United States alone [4] [10]. Among these, hormone receptor-positive (HR+), and HER2-negative breast cancer accounts for approximately 70% of…


